tiprankstipranks
Trending News
More News >
APONTIS PHARMA AG (DE:APPH)
XETRA:APPH
Germany Market

APONTIS PHARMA AG (APPH) Income Statement

Compare
6 Followers

APONTIS PHARMA AG Income Statement

Last quarter (Q2 2025), APONTIS PHARMA AG's total revenue was €26.03M, an increase of 36.60% from the same quarter last year. In Q2, APONTIS PHARMA AG's net income was €603.75K. See APONTIS PHARMA AG’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
€ 48.47M€ 36.96M€ 55.73M€ 51.18M€ 39.24M
Gross Profit
€ 27.70M€ -3.29M€ 34.99M€ 33.79M€ 25.03M
Operating Expenses
€ 26.44M€ 12.25M€ 31.18M€ 32.12M€ 25.64M
Depreciation and Amortization
€ 2.24M€ 1.88M€ 1.80M€ 1.75M€ 1.65M
EBITDA
€ 3.56M€ -12.94M€ 5.67M€ 1.99M€ 1.04M
Operating Income
€ 1.26M€ -15.10M€ 3.38M€ 1.91M€ -1.06M
Other Income/Expenses
€ -110.88K€ 273.21K€ 451.96K€ -1.42M€ -422.45K
Pretax Income
€ 1.15M€ -14.85M€ 3.83M€ 248.26K€ -1.48M
Net Income
€ 753.57K€ -11.30M€ 2.69M€ -745.24K€ -1.18M
Per Share Metrics
Basic EPS
€ 0.09€ -1.33€ 0.32€ -0.09€ -0.14
Diluted EPS
€ 0.09€ -1.33€ 0.32€ -0.09€ -0.14
Weighted Average Shares Outstanding
8.33M 8.50M 8.50M 8.50M 8.50M
Weighted Average Shares Outstanding (Diluted)
8.33M 8.50M 8.50M 8.50M 8.50M
Currency in EUR

APONTIS PHARMA AG Earnings and Revenue History